Fine Foods & Pharmaceuticals N.T.M. SpA

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: IT0005215329

EUR

9.84

0.2 (2.07%)

Dec 12

MIL

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Philogen SpA

Recordati SpA

Enervit SpA

Fine Foods & Pharmaceuticals N.T.M. SpA

Friulchem SpA

Bioera SpA

Valsoia SpA

Centrale del Latte d'Italia SpA

Why is Fine Foods & Pharmaceuticals N.T.M. SpA ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.14%

Poor long term growth as Operating profit has grown by an annual rate 187.54% of over the last 5 years
Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.21 times

Flat results in Dec 21

NO KEY NEGATIVE TRIGGERS

With ROE of 9.07%, it has a Expensive valuation with a 1.47 Price to Book Value

Over the past year, while the stock has generated a return of 24.87%, its profits have risen by 798.9% ; the PEG ratio of the company is 0

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Fine Foods & Pharmaceuticals N.T.M. SpA for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Fine Foods & Pharmaceuticals N.T.M. SpA

24.87%

0.44

26.82%

Italy FTSE MIB

24.83%

1.34

19.25%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.39%

EBIT Growth (5y)

187.54%

EBIT to Interest (avg)

1.77

Debt to EBITDA (avg)

2.21

Net Debt to Equity (avg)

0.32

Sales to Capital Employed (avg)

0.76

Tax Ratio

29.27%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

3.14%

ROE (avg)

2.06%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.47

EV to EBIT

13.42

EV to EBITDA

7.29

EV to Capital Employed

1.35

EV to Sales

1.01

PEG Ratio

0.02

Dividend Yield

ROCE (Latest)

10.02%

ROE (Latest)

9.07%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Fine Foods & Pharmaceuticals N.T.M. SpA

Raw Material Cost

Fallen by -324.76% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

At EUR 7.04 MM has Grown at 10.81%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (EUR MM)